Gold Short Term: Modestly Rising
George Lam July 6, 2020 3:47 AM
Spot gold has been modestly rising, as investors are weighing the resurgence of coronavirus infections against potential treatment for the virus.
U.S. coronavirus cases rose 2%, or about 56,000 on Sunday compared with the previous day, more than the seven-day average, according to Johns Hopkins University. Meanwhile, the World Health Organization also reported a one-day high in global Covid-19 infections over the weekend.
Spot gold has been modestly rising, as investors are weighing the resurgence of coronavirus infections against potential treatment for the virus. Last week, pharmaceutical giant Pfizer and German biotech company BioNTech announced early positive data of its Covid-19 vaccine and said they could possibly produce up to 100 million doses by the end of 2020.
From a technical point of view, spot gold remains on the upside as shown on the daily-chart, though has not yet accelerate its rally. In fact, it is holding up well after breaking above a 2-month consolidation range. Nevertheless, investors would have to notice that the daily RSI keeps showing a bearish divergence. The level at $1,715 might be considered as the nearest support, with prices trending to test the 1st and 2nd resistance $1,825 and $1,855 respectively. Alternatively, a break below $1,715 may trigger a deeper pull-back to test the next support at $1,675.
Disclaimer: StoneX Financial Ltd. (trading as "Forex.com") is an execution-only service provider. This material, whether or not it states any opinions, is for general information purposes only and it does not take into account your personal circumstances or objectives. This material has been prepared using the thoughts and opinions of the author and these may change. However, Forex.com does not plan to provide further updates to any material once published and it is not under any obligation to keep this material up to date. This material is short term in nature and may only relate to facts and circumstances existing at a specific time or day. Nothing in this material is (or should be considered to be) financial, investment, legal, tax or other advice and no reliance should be placed on it.
No opinion given in this material constitutes a recommendation by Forex.com or the author that any particular investment, security, transaction or investment strategy is suitable for any specific person. The material has not been prepared in accordance with legal requirements designed to promote the independence of investment research. Although Forex.com is not specifically prevented from dealing before providing this material, Forex.com does not seek to take advantage of the material prior to its dissemination. This material is not intended for distribution to, or use by, any person in any country or jurisdiction where such distribution or use would be contrary to local law or regulation.
For further details see our full non-independent research disclaimer and quarterly summary.